These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34994644)

  • 1. Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat.
    Kieran R; de Paula BHR; Hubank M; Barker A; Paterson AL; Gilligan D; Doherty GJ
    JCO Precis Oncol; 2021 Nov; 5():1579-1583. PubMed ID: 34994644
    [No Abstract]   [Full Text] [Related]  

  • 2. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
    Gounder M; Ratan R; Alcindor T; Schöffski P; van der Graaf WT; Wilky BA; Riedel RF; Lim A; Smith LM; Moody S; Attia S; Chawla S; D'Amato G; Federman N; Merriam P; Van Tine BA; Vincenzi B; Benson C; Bui NQ; Chugh R; Tinoco G; Charlson J; Dileo P; Hartner L; Lapeire L; Mazzeo F; Palmerini E; Reichardt P; Stacchiotti S; Bailey HH; Burgess MA; Cote GM; Davis LE; Deshpande H; Gelderblom H; Grignani G; Loggers E; Philip T; Pressey JG; Kummar S; Kasper B
    N Engl J Med; 2023 Mar; 388(10):898-912. PubMed ID: 36884323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma.
    Wang H
    Thorac Cancer; 2017 Nov; 8(6):729-733. PubMed ID: 28892250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
    Papayannidis C; DeAngelo DJ; Stock W; Huang B; Shaik MN; Cesari R; Zheng X; Reynolds JM; English PA; Ozeck M; Aster JC; Kuo F; Huang D; Lira PD; McLachlan KR; Kern KA; Garcia-Manero G; Martinelli G
    Blood Cancer J; 2015 Sep; 5(9):e350. PubMed ID: 26407235
    [No Abstract]   [Full Text] [Related]  

  • 5. Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiotherapy.
    Sasiaja M; Funa N; Kamata M; Furutani K; Matsumoto A; Kodaira T
    Clin Oncol (R Coll Radiol); 2000; 12(4):272. PubMed ID: 11005697
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of gamma-secretase inhibitor nirogacestat (PF-03084014) in desmoid tumor: Report of four pediatric/young adult cases.
    Takahashi T; Prensner JR; Robson CD; Janeway KA; Weigel BJ
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28636. PubMed ID: 32762028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresectable adenoid cystic carcinoma of the trachea treated with chemoradiation.
    Allen AM; Rabin MS; Reilly JJ; Mentzer SJ
    J Clin Oncol; 2007 Dec; 25(34):5521-3. PubMed ID: 18048830
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tracheal adenoid cystic carcinoma followed by tracheal squamous cell carcinoma: a case report].
    Peng D; Wang H; Cai C
    Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):58-60. PubMed ID: 23327876
    [No Abstract]   [Full Text] [Related]  

  • 9. Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
    J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
    Xie M; Wei S; Wu X; Li X; You Y; He C
    Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
    Wu CX; Xu A; Zhang CC; Olson P; Chen L; Lee TK; Cheung TT; Lo CM; Wang XQ
    Mol Cancer Ther; 2017 Aug; 16(8):1531-1543. PubMed ID: 28522590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
    López-Guerra M; Xargay-Torrent S; Rosich L; Montraveta A; Roldán J; Matas-Céspedes A; Villamor N; Aymerich M; López-Otín C; Pérez-Galán P; Roué G; Campo E; Colomer D
    Leukemia; 2015 Jan; 29(1):96-106. PubMed ID: 24781018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma.
    Panaccione A; Chang MT; Carbone BE; Guo Y; Moskaluk CA; Virk RK; Chiriboga L; Prasad ML; Judson B; Mehra S; Yarbrough WG; Ivanov SV
    Clin Cancer Res; 2016 Apr; 22(8):2083-95. PubMed ID: 27084744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nirogacestat: First Approval.
    Keam SJ
    Drugs; 2024 Mar; 84(3):355-361. PubMed ID: 38409573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cylindroma of the trachea, a rate tumor with unusual evolution].
    Bauduceau O; Ceccaldi B; Bernard O; Dourhte LM; Le Moulec S; Hervé R
    Presse Med; 2003 Apr; 32(13 Pt 1):602. PubMed ID: 12718319
    [No Abstract]   [Full Text] [Related]  

  • 16. Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.
    Chen X; Chen X; Zhou Z; Mao Y; Wang Y; Ma Z; Xu W; Qin A; Zhang S
    Exp Cell Res; 2019 Sep; 382(1):111470. PubMed ID: 31211955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
    Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
    Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NOTCH1-HEY1 pathway regulates self-renewal and epithelial-mesenchymal transition of salivary adenoid cystic carcinoma cells.
    Xie J; Lin LS; Huang XY; Gan RH; Ding LC; Su BH; Zhao Y; Lu YG; Zheng DL
    Int J Biol Sci; 2020; 16(4):598-610. PubMed ID: 32025208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma.
    Wang K; Fan HY; Pang X; Zhang M; Yu XH; Wu JS; Chen BJ; Jiang J; Liang XH; Tang YL
    Oncol Rep; 2021 Mar; 45(3):1011-1022. PubMed ID: 33469672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of primary tracheal adenoid cystic carcinoma: report of 11 cases].
    Zhao HG; Xu S; Zhang L; Hu YX; Liu HX; Du J
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jul; 26(7):400-2. PubMed ID: 12921643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.